Andrzej Joachimiak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Andrzej Joachimiak has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
Youngchang Kim
Center for Structural Biology of Infectious Diseases, University of Chicago, Chicago, Illinois, USA
37 shared publicationsRobert Jedrzejczak
University of Chicago
33 shared publicationsKarolina Michalska
University of Chicago
30 shared publicationsJerzy Osipiuk
Center for Structural Biology of Infectious Diseases, Feinberg School of Medicine, Northwestern University
23 shared publicationsGyorgy Babnigg
Argonne National Laboratory
22 shared publications- Aled Morgan Edwards
Structural Genomics Consortium
21 shared publications
Latest Publications
- 15 October 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 82 (11) , 1318
Protein structure of a glycoside hydrolase family 30, subfamily 12 endo-1,4-β-xylanase. Corrigendum
Two corrections are made to the article by St John et al. (2026).
- 15 October 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 82 (11) , 1318
Protein structure of a glycoside hydrolase family 30, subfamily 12 endo-1,4-β-xylanase. Corrigendum
Two corrections are made to the article by St John et al. (2026).
- Open Access
- 17 September 2026
- Published by Springer Nature in Communications Chemistry
Structural basis for substrate-assisted catalysis and small-molecule inhibition of alphavirus macrodomains
Sporadic alphavirus infections are pandemic threats that evade innate immunity via macrodomains which remove host mono-ADP-ribose (ADPr). Through high-resolution crystallography of apo and ADPr-bound forms, we here define a conserved MacroD-like fold and a shared hydrogen-bonding network for macrodomains from Eastern equine encephalitis (EEEV), Venezuelan equine encephalitis (VEEV), and Chikungunya (CHIKV) alphaviruses. Our detailed active site structures support a substrate-assisted hydrolysis mechanism where the ADPr α-phosphate activates the catalytic water for nucleophilic attack. Furthermore, we identify the suramin trisulfonic moiety as a potent inhibitor. Crystal structures with solution-state SAXS show suramin occupies the ADPr-binding pocket and induces reversible, inhibitor-mediated oligomerization. Biophysical and enzymatic assays confirm low-micromolar inhibition of EEEV glycohydrolase activity, while cell-based trans -replication assays demonstrate broad-spectrum suppression of EEEV, VEEV, and CHIKV replication. Collectively, our findings define the structural basis for alphaviral macrodomain catalysis, key alphaviral macrodomain druggable features, and a promising scaffold for targeted broad-spectrum antiviral therapeutics.
- 17 September 2026
- Published by Springer Nature in Communications Chemistry
Open AccessStructural basis for substrate-assisted catalysis and small-molecule inhibition of alphavirus macrodomains
Sporadic alphavirus infections are pandemic threats that evade innate immunity via macrodomains which remove host mono-ADP-ribose (ADPr). Through high-resolution crystallography of apo and ADPr-bound forms, we here define a conserved MacroD-like fold and a shared hydrogen-bonding network for macrodomains from Eastern equine encephalitis (EEEV), Venezuelan equine encephalitis (VEEV), and Chikungunya (CHIKV) alphaviruses. Our detailed active site structures support a substrate-assisted hydrolysis mechanism where the ADPr α-phosphate activates the catalytic water for nucleophilic attack. Furthermore, we identify the suramin trisulfonic moiety as a potent inhibitor. Crystal structures with solution-state SAXS show suramin occupies the ADPr-binding pocket and induces reversible, inhibitor-mediated oligomerization. Biophysical and enzymatic assays confirm low-micromolar inhibition of EEEV glycohydrolase activity, while cell-based trans -replication assays demonstrate broad-spectrum suppression of EEEV, VEEV, and CHIKV replication. Collectively, our findings define the structural basis for alphaviral macrodomain catalysis, key alphaviral macrodomain druggable features, and a promising scaffold for targeted broad-spectrum antiviral therapeutics.
- Open Access
- 17 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (38) , 57583-57594
Atomic-Level Structures Reveal How a Repurposed 3-Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase
Tuberculosis (TB) is again the world’s leading cause of death from a single infectious agent. Aminoacyl-tRNA synthetases are essential for protein synthesis and are promising drug targets because bacterial and human enzymes differ. We repurposed a human prolyl-tRNA synthetase (ProRS) inhibitor scaffold, 3-aminopyrazine-2-carboxamide, to inhibit the Mycobacterium tuberculosis enzyme (MtbProRS). These derivatives show strong activity against multidrug-resistant Mtb strains and are not cytotoxic to HepG2 cells. We determined high-resolution crystal structures of MtbProRS bound to six derivatives to define their binding modes. The compounds bind in the ATP site and trigger local conformational changes that disrupt the proline pocket, supporting a dual-site mechanism of inhibition. Comparison with human cytosolic and mitochondrial ProRS reveals differences in active-site residues, electrostatics, and dynamics that explain species selectivity. Together, these structures provide a framework for designing next-generation, Mtb-selective ProRS inhibitors as new antitubercular candidates.
- 17 September 2026
- Published by American Chemical Society (ACS) in ACS Omega
- Vol. 11 (38) , 57583-57594
Open AccessAtomic-Level Structures Reveal How a Repurposed 3-Aminopyrazine-2-carboxamide Scaffold Inhibits Mycobacterium tuberculosis Prolyl-tRNA Synthetase
Tuberculosis (TB) is again the world’s leading cause of death from a single infectious agent. Aminoacyl-tRNA synthetases are essential for protein synthesis and are promising drug targets because bacterial and human enzymes differ. We repurposed a human prolyl-tRNA synthetase (ProRS) inhibitor scaffold, 3-aminopyrazine-2-carboxamide, to inhibit the Mycobacterium tuberculosis enzyme (MtbProRS). These derivatives show strong activity against multidrug-resistant Mtb strains and are not cytotoxic to HepG2 cells. We determined high-resolution crystal structures of MtbProRS bound to six derivatives to define their binding modes. The compounds bind in the ATP site and trigger local conformational changes that disrupt the proline pocket, supporting a dual-site mechanism of inhibition. Comparison with human cytosolic and mitochondrial ProRS reveals differences in active-site residues, electrostatics, and dynamics that explain species selectivity. Together, these structures provide a framework for designing next-generation, Mtb-selective ProRS inhibitors as new antitubercular candidates.
- Open Access
Cryo-EM structure of detergent-bound Vibrio cholerae MakA captures a candidate intermediate between the soluble form and mature assembly of an α-pore-forming toxin
The tripartite toxin MakA/MakB/MakE from Vibrio cholerae belongs to a family of α-pore-forming toxins that undergo extensive conformational rearrangements upon interacting with membrane. While soluble structures of MakA, MakB and MakE have been determined, the structural basis of membrane association and pore assembly remains poorly understood. Here, we report a cryo-electron microscopy structure of a detergent-associated form of MakA at a global resolution of 3.13 Angstrom, with focused refinement of a flexible region improving the local resolution to 2.68 Angstrom. This structure consists of a trimer of MakA asymmetric homodimers, in which each subunit adopts a transmembrane α-helical conformation distinct from the previously reported soluble structure. The asymmetric homodimer closely resembles the building block observed in the previously reported helical MakA assembly and is structurally similar to the homodimeric building blocks of the Aeromonas hydrophila AhlB and Serratia marcescens SmhA pores, and the heterodimeric building blocks of the Xenorhabdus nematophila XaxAB and Yersinia enterocolitica YaxAB pores, suggesting a conserved assembly principle among distantly related α-pore-forming toxins. Complementary hydropathy analysis, AlphaFold2 modeling, and liposome-based assays reveal distinct roles for the three components, with MakA acting as the primary membrane-inserting subunit, MakE exhibiting low but consistent membrane-association, and MakB alone remaining largely soluble. Together, these results support a model in which the MakA asymmetric homodimer represents a plausible early membrane-insertion unit and building block for pore assembly, while the trimer of dimers represents an early assembly intermediate.
Open AccessCryo-EM structure of detergent-bound Vibrio cholerae MakA captures a candidate intermediate between the soluble form and mature assembly of an α-pore-forming toxin
The tripartite toxin MakA/MakB/MakE from Vibrio cholerae belongs to a family of α-pore-forming toxins that undergo extensive conformational rearrangements upon interacting with membrane. While soluble structures of MakA, MakB and MakE have been determined, the structural basis of membrane association and pore assembly remains poorly understood. Here, we report a cryo-electron microscopy structure of a detergent-associated form of MakA at a global resolution of 3.13 Angstrom, with focused refinement of a flexible region improving the local resolution to 2.68 Angstrom. This structure consists of a trimer of MakA asymmetric homodimers, in which each subunit adopts a transmembrane α-helical conformation distinct from the previously reported soluble structure. The asymmetric homodimer closely resembles the building block observed in the previously reported helical MakA assembly and is structurally similar to the homodimeric building blocks of the Aeromonas hydrophila AhlB and Serratia marcescens SmhA pores, and the heterodimeric building blocks of the Xenorhabdus nematophila XaxAB and Yersinia enterocolitica YaxAB pores, suggesting a conserved assembly principle among distantly related α-pore-forming toxins. Complementary hydropathy analysis, AlphaFold2 modeling, and liposome-based assays reveal distinct roles for the three components, with MakA acting as the primary membrane-inserting subunit, MakE exhibiting low but consistent membrane-association, and MakB alone remaining largely soluble. Together, these results support a model in which the MakA asymmetric homodimer represents a plausible early membrane-insertion unit and building block for pore assembly, while the trimer of dimers represents an early assembly intermediate.
- Open Access
Phylogenetic Analysis and Structural Evaluation of Staphylococcus aureus Serine-Aspartate Repeat-Containing Protein D with a Focus on Periprosthetic Joint Infection
Serine–aspartate repeat-containing protein D (SdrD) is a Staphylococcus aureus cell wall–anchored, calcium-binding adhesin member of the MSCRAMM Sdr subfamily that may contribute to bacterial adhesion and virulence. S. aureus is the most common cause of periprosthetic joint infection (PJI). Population-level distribution and sequence diversity of SdrD among clinical PJI isolates have not been systematically characterized, and the SdrD binding mechanism is still not well understood. To address these gaps, sdrD alleles were queried across 156 newly sequenced PJI isolates and compared to publicly available S. aureus genomes, and nucleotide– and protein-level phylogenies of the sdrCDE locus constructed. The SdrD crystal structure from S. aureus JH1 was determined, with solution small-angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations, and assessment of conformational changes with calcium depletion. Three dominant sdrD subtypes were defined, associating with USA300, JH1, and TCH60; the JH1 sdrD subtype was predominant among PJI isolates. Structural studies showed that the conformation of individual domains and interdomain organization of the multidomain SdrD have limited flexibility in solution, and that the calcium-binding B domain retains its core fold under conditions of calcium depletion. Together, the findings presented support functional diversification among Sdr family members in mediating host attachment and inform a re-evaluation of the ligand-binding mechanism previously proposed for SdrD. AUTHOR SUMMARY: Staphylococcus aureus is the leading cause of infections that develop around joint implants (periprosthetic joint infection, PJI). This bacterium has a large arsenal of surface proteins that allow it to stick to human tissues and implanted devices. This work focused on one such protein, SdrD, which has been linked to implant-associated infections but the structure and diversity of which among patients with PJI had not been well characterized. The genetic sequences of SdrD were analyzed across thousands of bacterial genomes, including those from patients with PJI. Distinct genetic variants of the protein were found, one of which was particularly common with PJI. The three-dimensional structure of SdrD was determined at atomic resolution and solution small-angle X-ray scattering (SAXS) and molecular dynamics used to study how it moves and responds to changes in its environment. Contrary to what was previously described, SdrD was shown to be relatively rigid. These findings change how SdrD’s mechanism of action should be considered, potentially informing design strategies to block bacterial attachment before infection takes hold.
Open AccessPhylogenetic Analysis and Structural Evaluation of Staphylococcus aureus Serine-Aspartate Repeat-Containing Protein D with a Focus on Periprosthetic Joint Infection
Serine–aspartate repeat-containing protein D (SdrD) is a Staphylococcus aureus cell wall–anchored, calcium-binding adhesin member of the MSCRAMM Sdr subfamily that may contribute to bacterial adhesion and virulence. S. aureus is the most common cause of periprosthetic joint infection (PJI). Population-level distribution and sequence diversity of SdrD among clinical PJI isolates have not been systematically characterized, and the SdrD binding mechanism is still not well understood. To address these gaps, sdrD alleles were queried across 156 newly sequenced PJI isolates and compared to publicly available S. aureus genomes, and nucleotide– and protein-level phylogenies of the sdrCDE locus constructed. The SdrD crystal structure from S. aureus JH1 was determined, with solution small-angle X-ray scattering (SAXS) and molecular dynamics (MD) simulations, and assessment of conformational changes with calcium depletion. Three dominant sdrD subtypes were defined, associating with USA300, JH1, and TCH60; the JH1 sdrD subtype was predominant among PJI isolates. Structural studies showed that the conformation of individual domains and interdomain organization of the multidomain SdrD have limited flexibility in solution, and that the calcium-binding B domain retains its core fold under conditions of calcium depletion. Together, the findings presented support functional diversification among Sdr family members in mediating host attachment and inform a re-evaluation of the ligand-binding mechanism previously proposed for SdrD. AUTHOR SUMMARY: Staphylococcus aureus is the leading cause of infections that develop around joint implants (periprosthetic joint infection, PJI). This bacterium has a large arsenal of surface proteins that allow it to stick to human tissues and implanted devices. This work focused on one such protein, SdrD, which has been linked to implant-associated infections but the structure and diversity of which among patients with PJI had not been well characterized. The genetic sequences of SdrD were analyzed across thousands of bacterial genomes, including those from patients with PJI. Distinct genetic variants of the protein were found, one of which was particularly common with PJI. The three-dimensional structure of SdrD was determined at atomic resolution and solution small-angle X-ray scattering (SAXS) and molecular dynamics used to study how it moves and responds to changes in its environment. Contrary to what was previously described, SdrD was shown to be relatively rigid. These findings change how SdrD’s mechanism of action should be considered, potentially informing design strategies to block bacterial attachment before infection takes hold.
- 23 March 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 82 (4) , 370-382
Protein structure of a glycoside hydrolase family 30, subfamily 12 endo-1,4-β-xylanase
We have determined the X-ray crystallographic protein structure of endo-1,4-β-xylanase (EX) A from Anaerobacterium chartisolvens ( Ach Xyn30A), a homologue of the recent biochemically characterized glycoside hydrolase family 30, subfamily 12 (GH30_12) EX from Acetivibrio clariflavus ( Ac Xyn30B). The N-terminal GH30 catalytic domains (CDs) of these two enzymes share approximately 63% amino-acid sequence identity and the full-length proteins each consist of the GH30_12 CD, a family 6 carbohydrate-binding module and a C-terminal dockerin domain. In this report, we offer additional support for the recent subfamily classification of these EXs and provide detailed X-ray crystallographic protein structure analysis of Ach Xyn30A, the first protein structure from this newly defined GH30 subfamily. We also provide comparative structural analysis using a generated Ac Xyn30B homology model as well as other GH30 subfamily enzymes. Additionally, we examine potential xylan-chain interactions informed by the protein structure. These characterized EXs further illustrate the diversity of xylan-degrading enzymes which have evolved within glycoside hydrolase family 30.
- 23 March 2026
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 82 (4) , 370-382
Protein structure of a glycoside hydrolase family 30, subfamily 12 endo-1,4-β-xylanase
We have determined the X-ray crystallographic protein structure of endo-1,4-β-xylanase (EX) A from Anaerobacterium chartisolvens ( Ach Xyn30A), a homologue of the recent biochemically characterized glycoside hydrolase family 30, subfamily 12 (GH30_12) EX from Acetivibrio clariflavus ( Ac Xyn30B). The N-terminal GH30 catalytic domains (CDs) of these two enzymes share approximately 63% amino-acid sequence identity and the full-length proteins each consist of the GH30_12 CD, a family 6 carbohydrate-binding module and a C-terminal dockerin domain. In this report, we offer additional support for the recent subfamily classification of these EXs and provide detailed X-ray crystallographic protein structure analysis of Ach Xyn30A, the first protein structure from this newly defined GH30 subfamily. We also provide comparative structural analysis using a generated Ac Xyn30B homology model as well as other GH30 subfamily enzymes. Additionally, we examine potential xylan-chain interactions informed by the protein structure. These characterized EXs further illustrate the diversity of xylan-degrading enzymes which have evolved within glycoside hydrolase family 30.
- Open Access
- 4 March 2026
- Published by Taylor & Francis in Synchrotron Radiation News
- Vol. 39 (2) , 12-17
Macromolecular Crystallography at the Upgraded Advanced Photon Source
- 4 March 2026
- Published by Taylor & Francis in Synchrotron Radiation News
- Vol. 39 (2) , 12-17
Open AccessMacromolecular Crystallography at the Upgraded Advanced Photon Source
- Open Access
- 29 January 2026
- Published by Springer Nature in Research Square
Structural basis for substrate-assisted catalysis and small-molecule inhibition of alphavirus macrodomains
Sporadic alphavirus infections are pandemic threats that evade innate immunity via macrodomains which remove host mono-ADP-ribose (ADPr). Through high-resolution crystallography of apo and ADPr-bound forms, we here define a conserved MacroD-like fold and a shared hydrogen-bonding network for macrodomains from Eastern equine encephalitis (EEEV), Venezuelan equine encephalitis (VEEV), and Chikungunya (CHIKV) alphaviruses. Our detailed active site structures support a substrate-assisted hydrolysis mechanism where the ADPr α-phosphate activates the catalytic water for nucleophilic attack. Furthermore, we identify the suramin trisulfonic moiety as a potent inhibitor. Crystal structures with solution-state SAXS show suramin occupies the ADPr-binding pocket and induces reversible, inhibitor-mediated oligomerization. Biophysical and enzymatic assays confirm low-micromolar inhibition of EEEV glycohydrolase activity, while cell-based trans-replication assays demonstrate broad-spectrum suppression of EEEV, VEEV, and CHIKV replication. Collectively, our findings define the structural basis for alphaviral macrodomain catalysis, key alphaviral macrodomain druggable features, and a promising scaffold for targeted broad-spectrum antiviral therapeutics.
- 29 January 2026
- Published by Springer Nature in Research Square
Open AccessStructural basis for substrate-assisted catalysis and small-molecule inhibition of alphavirus macrodomains
Sporadic alphavirus infections are pandemic threats that evade innate immunity via macrodomains which remove host mono-ADP-ribose (ADPr). Through high-resolution crystallography of apo and ADPr-bound forms, we here define a conserved MacroD-like fold and a shared hydrogen-bonding network for macrodomains from Eastern equine encephalitis (EEEV), Venezuelan equine encephalitis (VEEV), and Chikungunya (CHIKV) alphaviruses. Our detailed active site structures support a substrate-assisted hydrolysis mechanism where the ADPr α-phosphate activates the catalytic water for nucleophilic attack. Furthermore, we identify the suramin trisulfonic moiety as a potent inhibitor. Crystal structures with solution-state SAXS show suramin occupies the ADPr-binding pocket and induces reversible, inhibitor-mediated oligomerization. Biophysical and enzymatic assays confirm low-micromolar inhibition of EEEV glycohydrolase activity, while cell-based trans-replication assays demonstrate broad-spectrum suppression of EEEV, VEEV, and CHIKV replication. Collectively, our findings define the structural basis for alphaviral macrodomain catalysis, key alphaviral macrodomain druggable features, and a promising scaffold for targeted broad-spectrum antiviral therapeutics.
- Open Access
PANCS-spec-Binders: A system for rapidly discovering isoform– or epitope–specific binders
Proteins that bind to a target protein of interest, termed “binders,” are essential components of biological research reagents and therapeutics. Target proteins present multiple binding surfaces with varying interaction potential. High-potential surfaces, or “hot spots,” are experimentally identified as the most probable binding sites in de novo discovery campaigns. However, hot spots and their default binding modes do not always confer the desired specificity. Related proteins or isoforms often share similar hot spots, resulting in promiscuous binding. Interaction with a hot spot may also fail to elicit the intended biological outcome. Consequently, methods that direct de novo binder discovery toward targets with defined specificity are critically needed. We recently developed phage-assisted non-continuous selection of binders (PANCS-Binders), a selection platform with unparalleled speed and sequence-function fidelity that enables routine de novo binder discovery within days. However, because PANCS-Binder selections enrich variants based primarily on affinity, secondary screening is unlikely to identify binders to lesser hot spots because of the high likelihood of convergence. These alternative binding surfaces with weaker inherent interactions may possess desirable specificity profiles. Here, we develop PANCS-spec-Binders, which incorporates simultaneous selection and counterselection to control the specificity of enriched binders. We demonstrate PANCS-spec-Binders in two proof- of-concept applications: (1) discovery of isoform-selective binders that bind HRAS with >100-fold higher affinity than the highly related KRAS isoform, and (2) discovery of epitope-specific binders that either target or avoid the LIR interaction region of LC3B. PANCS-spec-Binders enables rapid identification of binders with defined specificity within days. SIGNIFICANCE: Affinity reagents, termed “binders”, are essential tools in research and therapeutic development. Binders generally require high specificity either at the selectivity level (binding only the target protein, but not related proteins) or at the epitope level (binding only at a specific surface on the target rather than another). While methods to discover binders in general have progressed, identifying binders with defined specificity features often requires extensive secondary screening and frequently results in failure. Here, we adapt our recently developed binder discovery platform to solve these two selectivity problems. By rapidly screening billions of variants, we can direct specificity between highly related proteins, direct binding to a specific epitope, and, because of the fidelity of our selections, identify binders that specifically avoid a defined epitope.
Open AccessPANCS-spec-Binders: A system for rapidly discovering isoform– or epitope–specific binders
Proteins that bind to a target protein of interest, termed “binders,” are essential components of biological research reagents and therapeutics. Target proteins present multiple binding surfaces with varying interaction potential. High-potential surfaces, or “hot spots,” are experimentally identified as the most probable binding sites in de novo discovery campaigns. However, hot spots and their default binding modes do not always confer the desired specificity. Related proteins or isoforms often share similar hot spots, resulting in promiscuous binding. Interaction with a hot spot may also fail to elicit the intended biological outcome. Consequently, methods that direct de novo binder discovery toward targets with defined specificity are critically needed. We recently developed phage-assisted non-continuous selection of binders (PANCS-Binders), a selection platform with unparalleled speed and sequence-function fidelity that enables routine de novo binder discovery within days. However, because PANCS-Binder selections enrich variants based primarily on affinity, secondary screening is unlikely to identify binders to lesser hot spots because of the high likelihood of convergence. These alternative binding surfaces with weaker inherent interactions may possess desirable specificity profiles. Here, we develop PANCS-spec-Binders, which incorporates simultaneous selection and counterselection to control the specificity of enriched binders. We demonstrate PANCS-spec-Binders in two proof- of-concept applications: (1) discovery of isoform-selective binders that bind HRAS with >100-fold higher affinity than the highly related KRAS isoform, and (2) discovery of epitope-specific binders that either target or avoid the LIR interaction region of LC3B. PANCS-spec-Binders enables rapid identification of binders with defined specificity within days. SIGNIFICANCE: Affinity reagents, termed “binders”, are essential tools in research and therapeutic development. Binders generally require high specificity either at the selectivity level (binding only the target protein, but not related proteins) or at the epitope level (binding only at a specific surface on the target rather than another). While methods to discover binders in general have progressed, identifying binders with defined specificity features often requires extensive secondary screening and frequently results in failure. Here, we adapt our recently developed binder discovery platform to solve these two selectivity problems. By rapidly screening billions of variants, we can direct specificity between highly related proteins, direct binding to a specific epitope, and, because of the fidelity of our selections, identify binders that specifically avoid a defined epitope.
- Open Access
- 12 June 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (6) , e0020025
Structural genomics of bacterial drug targets: Application of a high-throughput pipeline to solve 58 protein structures from pathogenic and related bacteria
Antibiotic resistance remains a leading cause of severe infections worldwide. Small changes in protein sequence can impact antibiotic efficacy. Here, we report deposition of 58 X-ray crystal structures of bacterial proteins that are known targets for antibiotics, which expands knowledge of structural variation to support future antibiotic discovery or modifications.
- 12 June 2025
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 14 (6) , e0020025
Open AccessStructural genomics of bacterial drug targets: Application of a high-throughput pipeline to solve 58 protein structures from pathogenic and related bacteria
Antibiotic resistance remains a leading cause of severe infections worldwide. Small changes in protein sequence can impact antibiotic efficacy. Here, we report deposition of 58 X-ray crystal structures of bacterial proteins that are known targets for antibiotics, which expands knowledge of structural variation to support future antibiotic discovery or modifications.